---
figid: PMC4904747__AJTS-10-1-g016
figtitle: JAK STAT pathway
organisms:
- Homo sapiens
- Mus musculus
- Helicobacter pylori
organisms_ner:
- Mus musculus
- Homo sapiens
pmcid: PMC4904747
filename: AJTS-10-1-g016.jpg
figlink: /pmc/articles/PMC4904747/figure/F16/
number: F16
caption: JAK STAT pathway. Ruxolitinib acts on this pathway for treating myeloproliferative
  neoplasms especially primary myelofibrosis
papertitle: Is cancer chemotherapy dying?.
reftext: M. B. Agarwal. Asian J Transfus Sci. 2016 May;10(Suppl 1):S1-S7.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.933885
figid_alias: PMC4904747__F16
figtype: Figure
redirect_from: /figures/PMC4904747__F16
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4904747__AJTS-10-1-g016.html
  '@type': Dataset
  description: JAK STAT pathway. Ruxolitinib acts on this pathway for treating myeloproliferative
    neoplasms especially primary myelofibrosis
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Jak2
  - Jak1
  - Stat1
  - JAK2
  - JAK1
  - STAT1
---
